Nachrichten zur Regeneron Pharmaceuticals Inc. Aktie

Regeneron: FDA Extends Evkeeza Approval to Children Ages 5 to 11 >REGN

Regeneron: FDA Extends Evkeeza Approval to Children Ages 5 to 11 >REGN...…

Regeneron (REGN) Gains But Lags Market: What You Should Know

Regeneron (REGN) closed the most recent trading day at $759.76, moving +0.07% from the previous trading session....…

Sanofi, Regeneron Dupixent gets approval in EU to treat eczema in kids over 6 months

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Sanofi/Regeneron say Dupixent skin treatment wins new regulatory approval in Europe

...PARIS, March 21 (Reuters) - Healthcare companies Sanofi and Regeneron......…

Regeneron (REGN) Gains 9.3% in a Year: Will the Uptrend Last?

Regeneron (REGN) has had a good run in the past 12 months and the momentum should continue in 2023 on…

Regeneron (REGN) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Regeneron (REGN) closed at $760.30, marking a -0.85% move from the previous day....…

Students Win More Than $1.8 Million at 2023 Regeneron Science Talent Search for Remarkable Scientific Research on RNA Molecule Structure, Media Bias, and Diagnostics for Pediatric Heart Disease

$250,000 top award goes to Neel Moudgal in the nations oldest and most prestigious science and math competition for high…

Regeneron Pharmaceuticals: Neues Kursziel

Toronto (www.aktiencheck.de) - Rating-Update: Brian Abrahams, Analyst vom Investmenthaus RBC Capital Markets, belässt die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075,…

Regeneron Borrows From Big Pharma Playbook

Eylea, the companys top-selling blockbuster, isnt going away soon....…

Regeneron (REGN) Stock Moves -0.19%: What You Should Know

Regeneron (REGN) closed the most recent trading day at $743.75, moving -0.19% from the previous trading session....…

2 Biotech Stocks You Can Buy and Hold for the Next Decade

Regeneron and Sarepta Therapeutics have been on fire so far this year....…

Sanofi (SNY), Regeneron Dupixent sBLA Accepted for FDA Review

Sanofis (SNY) sBLA seeking label expansion of drug Dupixent for chronic spontaneous urticaria accepted by the FDA...…

Regeneron wins EU nod for Libtayo in PD-L1 positive lung cancer

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron: CHMP Backs Libtayo/Chemotherapy Combo in Advanced Non-Small Cell Lung Cancer

Regeneron: CHMP Backs Libtayo/Chemotherapy Combo in Advanced Non-Small Cell Lung Cancer...…

Regeneron Pharmaceuticals: Neues Kursziel

San Francisco (www.aktiencheck.de) - Rating-Update: Mohit Bansal, Analyst von Wells Fargo Advisors, stuft die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075,…

MARKETVUE® REPORT: Over 80% of U.S. gastroenterologists have prescribed Dupixent for Eosinophilic Esophagitis since its 2022 approval

First-to-market Regeneron/Sanofis Dupixent (dupilumab) sees strong uptake in Eosinophilic Esophagitis (EoE) since its May 2022 FDA approval, according to findings…

Regeneron Gets FDA Priority Review of Pozelimab in Chaple >REGN

Regeneron Gets FDA Priority Review of Pozelimab in Chaple >REGN...…

9 Healthcare Stocks That Fewer Bears Target

Cigna, Regeneron, Centene, and six other healthcare stocks have seen short interest drop by at least 40% recently. Fewer investors…

Regeneron wins FDA nod for Eylea to prevent infant blindness

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: Aufsichtsrat verkauft Aktien von Regeneron Pharmaceuticals im Wert von 2.890.400$

Goldstein, Joseph L. - Aufsichtsrat - Tag der Transaktion: 2023-02-06...…

Insiderhandel: EVP Finance CFO verkauft Aktien von Regeneron Pharmaceuticals im Wert von 564.966$

Landry, Robert E. - Vorstand - Tag der Transaktion: 2023-02-03...…

Insiderhandel: Aufsichtsrat verkauft Aktien von Regeneron Pharmaceuticals im Wert von 795.359$

Bassler, Bonnie L. - Aufsichtsrat - Tag der Transaktion: 2023-02-03...…

Insiderhandel: EVP Finance CFO verkauft Aktien von Regeneron Pharmaceuticals im Wert von 593.238$

Landry, Robert E. - Vorstand - Tag der Transaktion: 2023-02-06...…

Thinking about trading options or stock in Catalent, Tesla, IDEXX Laboratories, Exxon Mobil, or Regeneron Pharmaceuticals?

NEW YORK, Feb. 6, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CTLT, TSLA, IDXX, XOM, and REGN. Click…

Form 10-K REGENERON PHARMACEUTICAL For: Dec 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: Aufsichtsrat verkauft Aktien von Regeneron Pharmaceuticals im Wert von 75.615$

Ryan, Arthur F. - Aufsichtsrat - Tag der Transaktion: 2023-02-01...…

Insiderhandel: EVP Commercial verkauft Aktien von Regeneron Pharmaceuticals im Wert von 827.409$

Mccourt, Marion - Vorstand - Tag der Transaktion: 2023-02-01...…

Dow & Co im Minus, Tech-Werte deutlich unter Druck: American Express, Apple, Regeneron und Tesla dennoch stark, Amazon, Home Depot und Microsoft schwach – der Tag an der Wall Street

Gewinnmitnahmen haben zum Wochenschluss die jüngste Rally der US-Technologiewerte ausgebremst. Für Ernüchterung sorgten enttäuschende Quartalsberichte zweier Schwergewichte der Tech-Branche. Hinzu…

Compared to Estimates, Regeneron (REGN) Q4 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Regeneron (REGN) give a sense of how the business performed in the quarter…

Regeneron (REGN) Q4 Earnings & Sales Beat, Eylea Sales Decline

Regeneron (REGN) tops earnings and sales estimates for the fourth quarter. However, sales of the lead drug Eylea decline year…

Regeneron (REGN) Q4 Earnings and Revenues Beat Estimates

Regeneron (REGN) delivered earnings and revenue surprises of 29.75% and 7.84%, respectively, for the quarter ended December 2022. Do the…

Regeneron posts Q4 beat as COVID therapy offsets Eylea impact

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron Pharma Q4 Profit Declines; Adj. Total Revenues Up 14%

WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals, Inc. (REGN) reported fourth-quarter adjusted profit per share of $12.56 compared to $23.42, prior year.…

Form 8-K REGENERON PHARMACEUTICAL For: Feb 03

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron Pharmaceuticals Q4 Profit Declines

WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals (REGN) released earnings for fourth quarter that decreased from last yearThe companys earnings came in…

UPDATE 1-Regeneron quarterly profit plunges as COVID drug sales dry up

...(Adds quarter details, background) Feb 3 (Reuters) - Regeneron......…

Regeneron stock rallies after profit and revenue beat expectations by wide margins

Shares of Regeneron Pharmaceuticals Inc. REGN rallied 1.9% toward a two-month high in premarket trading Friday, after the biotechnology company…

CORRECTED-Regeneron quarterly profit drops 46%

... in paragraph 2) Feb 3 (Reuters) - Regeneron Pharmaceuticals Inc reported......…

Regeneron Pharmaceuticals reports Q4 earnings beat; initiates FY23 guidance

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Regeneron quarterly profit drops 46%

...(Reuters) - Regeneron Pharmaceuticals Inc reported an about 46......…

Regeneron Reports Fourth Quarter and Full Year 2022 Financial and Operating Results

TARRYTOWN, N.Y., Feb. 03, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial results for…

DAX: US-Arbeitsmarktdaten am Nachmittag, Sanofi, Regeneron, ThyssenKrupp, Verbio, Apple, Amazon und Alphabet im Fokus – das ist heute wichtig

Nach der Vortagesrally dürften es die Anleger am Freitag am deutschen Aktienmarkt zunächst langsamer angehen lassen. Der Broker IG taxierte…

dpa-AFX ProFeed